JP2006513992A5 - - Google Patents

Download PDF

Info

Publication number
JP2006513992A5
JP2006513992A5 JP2004543586A JP2004543586A JP2006513992A5 JP 2006513992 A5 JP2006513992 A5 JP 2006513992A5 JP 2004543586 A JP2004543586 A JP 2004543586A JP 2004543586 A JP2004543586 A JP 2004543586A JP 2006513992 A5 JP2006513992 A5 JP 2006513992A5
Authority
JP
Japan
Prior art keywords
inclusion
polymer
polymer composition
linker molecule
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004543586A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006513992A (ja
JP4602085B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/031991 external-priority patent/WO2004032862A2/en
Publication of JP2006513992A publication Critical patent/JP2006513992A/ja
Publication of JP2006513992A5 publication Critical patent/JP2006513992A5/ja
Application granted granted Critical
Publication of JP4602085B2 publication Critical patent/JP4602085B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004543586A 2002-10-09 2003-10-08 シクロデキストリンを基材とした物質、組成物及びこれらと関連する用途 Expired - Fee Related JP4602085B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41737302P 2002-10-09 2002-10-09
PCT/US2003/031991 WO2004032862A2 (en) 2002-10-09 2003-10-08 Cyclodextrin-based materials, compositions and uses related thereto

Publications (3)

Publication Number Publication Date
JP2006513992A JP2006513992A (ja) 2006-04-27
JP2006513992A5 true JP2006513992A5 (https=) 2006-08-17
JP4602085B2 JP4602085B2 (ja) 2010-12-22

Family

ID=32094010

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004543586A Expired - Fee Related JP4602085B2 (ja) 2002-10-09 2003-10-08 シクロデキストリンを基材とした物質、組成物及びこれらと関連する用途

Country Status (13)

Country Link
US (3) US8357377B2 (https=)
EP (1) EP1549269A4 (https=)
JP (1) JP4602085B2 (https=)
KR (1) KR20050051686A (https=)
CN (1) CN1717209A (https=)
AU (1) AU2003295344B2 (https=)
BR (1) BR0315198A (https=)
CA (1) CA2501132A1 (https=)
MX (1) MXPA05003591A (https=)
RU (1) RU2005114007A (https=)
TW (1) TW200423960A (https=)
WO (1) WO2004032862A2 (https=)
ZA (1) ZA200502754B (https=)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2377318T3 (es) 2002-09-06 2012-03-26 Cerulean Pharma Inc. Polímeros a base de ciclodextrina para el suministro de los agentes terapéuticos enlazados covalentemente a ellos
KR20050051686A (ko) 2002-10-09 2005-06-01 인설트 테라페틱스, 인코퍼레이티드 사이클로덱스트린-기초한 재료, 조성물 및 이의 용도
SG129240A1 (en) * 2003-01-23 2007-02-26 Agency Science Tech & Res Biodegradable copolymer and nucleic acid delivery system
US7605120B2 (en) * 2003-10-22 2009-10-20 Amgen Inc. Antagonists of the brandykinin B1 receptor
US20070020299A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
US20070020298A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
US20070020196A1 (en) * 2003-12-31 2007-01-25 Pipkin James D Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension
AU2004311478A1 (en) 2003-12-31 2005-07-21 Cydex Pharmaceuticals, Inc. Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
WO2005088655A1 (en) * 2004-03-12 2005-09-22 The Provost Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin A magnetoresistive medium
WO2006012958A2 (en) * 2004-07-01 2006-02-09 The Netherlands Cancer Institute Combination comprising a bcrp inhibitor and 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide
JP2008537551A (ja) 2005-03-31 2008-09-18 カランド ファーマシューティカルズ， インコーポレイテッド リボヌクレオチドレダクターゼサブユニット２の阻害剤およびその使用
JPWO2006115211A1 (ja) * 2005-04-25 2008-12-18 株式会社カネカ シクロデキストリン含有ポリエステル系重合体及びその製造方法
WO2007009265A1 (en) * 2005-07-22 2007-01-25 The Governors Of The University Of Alberta Tec Edmonton NOVEL β-CYCLODEXTRIN-BASED MOLECULES AND DRUG DELIVERY COMPOSITIONS
US20070178050A1 (en) * 2005-12-20 2007-08-02 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids having an increased lung depositon
US20070185066A1 (en) * 2005-12-20 2007-08-09 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070249572A1 (en) * 2005-12-20 2007-10-25 Verus Pharmaceuticals, Inc. Systems and methods for the delivery of corticosteroids
US20070160542A1 (en) * 2005-12-20 2007-07-12 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
US20070197486A1 (en) * 2005-12-20 2007-08-23 Verus Pharmaceuticals, Inc. Methods and systems for the delivery of corticosteroids
JP2007211060A (ja) * 2006-02-07 2007-08-23 Japan Advanced Institute Of Science & Technology Hokuriku 超分子ポリマー及びその合成方法
JP2009526858A (ja) * 2006-02-15 2009-07-23 ティカ レーケメデル アーベー コルチコステロイド溶液を製造する方法
KR100809046B1 (ko) * 2006-03-10 2008-03-03 가톨릭대학교 산학협력단 풀루란을 가진 나노자가응집체 및 이의 이용방법
US20080027212A1 (en) 2006-06-28 2008-01-31 Skinner Keith K Methods and compositions for improved uptake of biological molecules
CN101568351B (zh) * 2006-12-22 2012-05-30 3M创新有限公司 控制释放的组合物和方法
US20080176958A1 (en) 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery
WO2008112993A1 (en) 2007-03-15 2008-09-18 Ventana Medical Systems, Inc. Stabilized hematoxylin
JP5681485B2 (ja) 2007-04-27 2015-03-11 サイデックス・ファーマシューティカルズ・インコーポレイテッド クロピドグレルおよびスルホアルキルエーテルシクロデキストリンを含有する製剤ならびに使用方法
US12370352B2 (en) 2007-06-28 2025-07-29 Cydex Pharmaceuticals, Inc. Nasal and ophthalmic delivery of aqueous corticosteroid solutions
WO2009001364A2 (en) * 2007-06-28 2008-12-31 Capsutech Ltd Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers
ITMI20071321A1 (it) * 2007-07-04 2009-01-05 Sea Marconi Technologies Di Va Nanospugne a base di ciclodestrine come veicolo per farmaci antitumorali
AU2009232355A1 (en) 2008-04-04 2009-10-08 Calando Pharmaceuticals, Inc. Compositions and use of EPAS1 inhibitors
US10463677B2 (en) 2008-11-07 2019-11-05 Cydex Pharmaceuticals, Inc. Composition containing sulfoalkyl ether cyclodextrin and latanoprost
WO2010088286A1 (en) * 2009-01-28 2010-08-05 Smartcells, Inc. Synthetic conjugates and uses thereof
WO2010088282A1 (en) * 2009-01-30 2010-08-05 Rgo Biosciences Llc Nucleic acid binding assays
WO2010099466A2 (en) * 2009-02-26 2010-09-02 The Regents Of The University Of California A supramolecular approach for preparation of size controllable nanoparticles
CA2761455C (en) 2009-05-13 2018-06-12 Cydex Pharmaceuticals, Inc. Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
US11020363B2 (en) 2009-05-29 2021-06-01 Cydex Pharmaceuticals, Inc. Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
PL2434886T3 (pl) 2009-05-29 2020-05-18 Cydex Pharmaceuticals, Inc. Kompozycje do wstrzykiwania melfalanu zawierające pochodną cyklodekstryny i sposoby ich wytwarzania i stosowania
US10045937B2 (en) * 2009-06-03 2018-08-14 Case Western Reserve University Therapeutic agent delivery system and method
IN2012DN02345A (https=) 2009-09-16 2015-08-21 Univ Duke
PT2501413T (pt) * 2009-11-18 2019-07-10 Nektar Therapeutics Formas de sal de ácido de conjugados de polímero-fármaco
CN102781237A (zh) 2009-11-23 2012-11-14 天蓝制药公司 用于传递治疗剂的基于环糊精的聚合物
US20110178287A1 (en) 2010-01-19 2011-07-21 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutic delivery
US20110300150A1 (en) * 2010-05-18 2011-12-08 Scott Eliasof Compositions and methods for treatment of autoimmune and other disease
US20120213854A1 (en) * 2010-09-30 2012-08-23 Fetzer Oliver S Methods of treating a subject and related particles, polymers and compositions
EP2635273B1 (en) 2010-11-01 2020-01-08 MEI Pharma, Inc. Isoflavonoid compositions and methods for the treatment of cancer
WO2013013245A2 (en) * 2011-07-21 2013-01-24 The Regents Of The University Of California Catalytic delivery nanoubstrates (cdns) for highly efficient delivery of biomolecules
CN103289075B (zh) * 2012-02-22 2016-01-20 天津键凯科技有限公司 聚乙二醇与纳洛酮的结合物及其药物组合物和应用
FR2989001B1 (fr) * 2012-04-06 2017-07-21 Centre Nat Rech Scient Microparticules et nanoparticules constituees de polysaccharides hydrophobises et d'une alpha-cyclodextrine
US9598503B2 (en) 2012-04-18 2017-03-21 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
US9827321B2 (en) 2012-08-14 2017-11-28 The Trustees Of The University Of Pennsylvania Stabilizing shear-thinning hydrogels
US20140094432A1 (en) 2012-10-02 2014-04-03 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
JP6445453B2 (ja) * 2012-11-28 2018-12-26 ビクトリア リンク リミテッド 樹状コア化合物
CN105358136B (zh) * 2013-02-15 2018-11-13 加利福尼亚大学董事会 超分子磁性纳米粒子
NZ629474A (en) 2013-02-27 2016-03-31 Crayola Llc Rinsable inks and methods of making the same
DE102013021060A1 (de) * 2013-12-18 2015-06-18 Rathor Ag Verfahren zur Abtrennung von Monomeren aus isocyanathaltigen Prepolymeren
US10329386B2 (en) 2014-07-08 2019-06-25 Osaka University Self-restoring macromolecular material and production method for same
GB2540914B (en) 2014-07-09 2021-11-24 Halliburton Energy Services Inc Treatment fluids for reducing subterranean formation damage
CN116139125A (zh) 2015-02-02 2023-05-23 梅制药公司 联合治疗
WO2016201523A1 (en) 2015-06-19 2016-12-22 The University Of Queensland Composition
CN105999289B (zh) * 2016-04-01 2018-11-20 南开大学 一种二元超两亲性纳米粒子溶液及其制备方法和应用
CN106349396A (zh) * 2016-08-26 2017-01-25 湖南尔康制药股份有限公司 一种具有超声敏感性的交联淀粉
US12447464B2 (en) 2016-12-22 2025-10-21 Duke University Polycationic microfibers and methods of using the same
CN112011040B (zh) * 2020-07-20 2021-08-17 广州医科大学 一种多重纳米传递系统及其制备方法
EP4192509A1 (en) 2020-08-05 2023-06-14 Ellipses Pharma Ltd Treatment of cancer using a cyclodextrin-containing polymer-topoisomerase inhibitor conjugate and a parp inhibitor
KR20230137391A (ko) * 2021-02-25 2023-10-04 노블 파나시아 랩스, 인크. 제어된 약물 방출을 위한 유기 초분자 혈관구조체의 어셈블리(assembly of organic supramolecular vessels for controlled drug release)
WO2026085322A1 (en) 2024-10-18 2026-04-23 Aardvark Therapeutics Inc. Isoflavonoid formulations and methods of use

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1390479A (en) 1973-09-05 1975-04-16 I Orch Sinteza Akademii Nauk L Pharmaceutical composition for treatment of parkinsonism
DE2842862A1 (de) * 1978-10-02 1980-04-10 Boehringer Mannheim Gmbh Verfahren zur bestimmung von ionen, polaren und/oder lipophilen substanzen in fluessigkeiten
CH663951A5 (fr) * 1984-10-10 1988-01-29 Nestle Sa Procede d'enrichissement selectif en acides gras polyinsatures d'un melange contenant des acides gras fractions enrichies obtenues et compositions les contenant.
US4841081A (en) * 1985-10-16 1989-06-20 Osaka Soda Co., Ltd. Method of optically resolving a racemate or a diastereomeric mixture of glycidyl compound
GB2197720A (en) 1986-11-20 1988-05-25 Nat Res Dev Immobilisation of polynucleotides
JP2993967B2 (ja) * 1987-06-17 1999-12-27 インスティテュート・フォー・チャイルド・ヘルス・リサーチ ダニアレルゲンのクローニング
US4877778A (en) * 1987-07-01 1989-10-31 The Children's Medical Center Corporation Method of enhancing lipophile transport using cyclodextrin derivatives
JP2614081B2 (ja) * 1988-05-27 1997-05-28 大塚化学株式会社 光学活性β−ラクタム誘導体の製造法
US4887778A (en) * 1988-06-01 1989-12-19 Universal Instruments Corporation Feeder drive assembly and replaceable section for tape supplying and cover peeling
HU200913B (en) 1988-07-28 1990-09-28 Ciklodextrin Kutato Fejlesztoe Process for producing infusion stock-solution containing pharmaceutically active components of bad water solubility
US5098793A (en) * 1988-09-29 1992-03-24 Uop Cyclodextrin films on solid substrates
US5139687A (en) 1990-05-09 1992-08-18 The Proctor & Gamble Company Non-destructive carriers for cyclodextrin complexes
JPH0425505A (ja) * 1990-05-21 1992-01-29 Toppan Printing Co Ltd シクロデキストリンポリマー及びシクロデキストリン膜の製造方法
KR927003647A (ko) * 1990-11-30 1992-12-18 돕빵 인사쯔 가부시끼가이샤 시클로덱스트린유도체 및 시클로덱스트린 고정화 폴리머의 제조방법
JP2976154B2 (ja) * 1991-11-27 1999-11-10 コニカ株式会社 ハロゲン化銀写真感光材料用固形処理剤
HU210922B (en) 1993-05-24 1995-09-28 Europharmaceuticals Sa Nimesulide alkali salt cyclodextrin inclusion complexes their preparation and pharmaceutical compositions containing them
US5880154A (en) * 1994-02-01 1999-03-09 The Board Of Regents Of The University Of Nebraska Polymeric adamantane analogues
HU218280B (en) * 1994-04-26 2000-07-28 Cyclodextrin inclusion complexes containing sin-1a which are stable intheir solid state, process for their preparation and pharmaceutical compositions containing the comlexes
US5691316A (en) * 1994-06-01 1997-11-25 Hybridon, Inc. Cyclodextrin cellular delivery system for oligonucleotides
JP3699141B2 (ja) 1994-09-24 2005-09-28 伸彦 由井 超分子構造の生体内分解性医薬高分子集合体及びその調製方法
US5728804A (en) * 1995-06-02 1998-03-17 Research Corporation Technologies, Inc. Use of cyclodextrins for protein renaturation
US6667293B1 (en) * 1995-09-12 2003-12-23 Hybridon, Inc. Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response
US6630351B1 (en) 1999-06-07 2003-10-07 Mirus Corporation Compositions and methods for drug delivery using pH sensitive molecules
US5844030A (en) * 1996-07-09 1998-12-01 Andros; Nicholas Charged ion cleaning devices and cleaning system
DE19629494A1 (de) * 1996-07-09 1998-01-15 Schering Ag Pseudopolyrotaxane
JP2001524097A (ja) 1997-04-23 2001-11-27 ユニバーシティ オブ オタゴ 眼用組成物の制御放出
JPH11100401A (ja) * 1997-07-30 1999-04-13 Kikkoman Corp 環状オリゴ糖及びそれを含むレトロウイルス性疾患の予防または治療剤
CA2302316A1 (en) * 1997-09-15 1999-03-25 Genetic Immunity, Llc. Method of delivering genes to antigen presenting cells of the skin
IT1298732B1 (it) 1998-03-13 2000-02-02 Recordati Chem Pharm Composizioni farmaceutiche orali assumibili senza liquidi,contenenti complessi di inclusione
US6048736A (en) 1998-04-29 2000-04-11 Kosak; Kenneth M. Cyclodextrin polymers for carrying and releasing drugs
US7091192B1 (en) * 1998-07-01 2006-08-15 California Institute Of Technology Linear cyclodextrin copolymers
US6509323B1 (en) 1998-07-01 2003-01-21 California Institute Of Technology Linear cyclodextrin copolymers
US6261583B1 (en) * 1998-07-28 2001-07-17 Atrix Laboratories, Inc. Moldable solid delivery system
US6703381B1 (en) 1998-08-14 2004-03-09 Nobex Corporation Methods for delivery therapeutic compounds across the blood-brain barrier
EP1133318B1 (en) 1998-12-04 2007-03-14 California Institute of Technology Supramolecular complexes containing therapeutic agents
US7375096B1 (en) * 1998-12-04 2008-05-20 California Institute Of Technology Method of preparing a supramolecular complex containing a therapeutic agent and a multi-dimensional polymer network
US6740643B2 (en) * 1999-01-21 2004-05-25 Mirus Corporation Compositions and methods for drug delivery using amphiphile binding molecules
WO2000075162A1 (en) 1999-06-07 2000-12-14 Mirus Corporation A compound containing a labile disulfide bond
EP1233671A4 (en) 1999-11-29 2005-11-02 Mirus Corp COMPOSITIONS AND METHODS OF DISPOSING MEDICAMENTS USING AMPHIPHILIC BINDING MOLECULARS
SK282717B6 (sk) 2000-03-10 2002-11-06 �Stav Experiment�Lnej Farmakol�Gie Sav Spôsob prípravy ultravysokomolekulových hyalurónanov
WO2002010392A2 (en) * 2000-08-01 2002-02-07 Oregon Health & Science University Mammalian dna binding membrane-associated protein-encoding gene and uses
TWI321054B (en) * 2000-12-19 2010-03-01 California Inst Of Techn Compositions containing inclusion complexes
US7141540B2 (en) * 2001-11-30 2006-11-28 Genta Salus Llc Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof
ES2377318T3 (es) * 2002-09-06 2012-03-26 Cerulean Pharma Inc. Polímeros a base de ciclodextrina para el suministro de los agentes terapéuticos enlazados covalentemente a ellos
KR20050051686A (ko) 2002-10-09 2005-06-01 인설트 테라페틱스, 인코퍼레이티드 사이클로덱스트린-기초한 재료, 조성물 및 이의 용도
US20080176958A1 (en) * 2007-01-24 2008-07-24 Insert Therapeutics, Inc. Cyclodextrin-based polymers for therapeutics delivery

Similar Documents

Publication Publication Date Title
JP2006513992A5 (https=)
Abourehab et al. Recent advances of chitosan formulations in biomedical applications
RU2005114007A (ru) Материалы на основе циклодекстринов, их композиции и применение
Zhao et al. Advanced bioactive nanomaterials for biomedical applications
Rial-Hermida et al. Recent progress on polysaccharide-based hydrogels for controlled delivery of therapeutic biomolecules
Zhang et al. Surface chemistry of gold nanoparticles for health-related applications
Jeong et al. Supramolecular hydrogels for precisely controlled antimicrobial peptide delivery for diabetic wound healing
Yang et al. Nanostructured antimicrobial peptides: crucial steps of overcoming the bottleneck for clinics
Ding et al. Weak bond-based injectable and stimuli responsive hydrogels for biomedical applications
Law et al. Peptide-based biomaterials for protease-enhanced drug delivery
EP2087910B1 (en) Polymeric prodrugs
Kulkarni et al. Peptide-chitosan engineered scaffolds for biomedical applications
Galanakou et al. Amphiphilic dendrimers against antibiotic resistance: light at the end of the tunnel?
JP2010524849A5 (https=)
HRP20041108B1 (hr) Peptidi povezani sa tumorom koji se vežu na mhc molekule
CN1961027A (zh) 新的水溶性富勒烯、其生产方法和含有该富勒烯的活性氧发生器
Liang et al. Injectable DNA hydrogels with intrinsic antioxidant and anti-inflammatory functions for effectively healing bacteria-infected diabetic wounds
Hu et al. Mechanisms of hydrogel-based microRNA delivery systems and its application strategies in targeting inflammatory diseases
JP2013517226A5 (ja) ウイルス、バクテリア、寄生生物に感染した細胞及び／又は腫瘍細胞に影響を及ぼす生物学的有効分子群、及び該分子群を適用するための方法
CN107744593B (zh) 一种叶酸靶向抗肿瘤药物缓释载体及其制备方法
Jia et al. Bottlebrush polymer-conjugated melittin exhibits enhanced antitumor activity and better safety profile
Li et al. Peptide‐based nanoarchitectonics for the treatment of liver fibrosis
Hegde et al. An update on design and pharmacology of dendritic poly (l-lysine)
CN1503679A (zh) 形成自聚集体的抗癌药-脱乙酰壳多糖复合体以及其制备方法
Zainuddin et al. Chitosan-based oral drug delivery system for peptide, protein and vaccine delivery